| Expression pattern: |
UP |
| Associated gene: |
IGF2BP1, AGO2 |
| Associated microRNA: |
miR-2110 |
| Biological function: |
Promotes HCC progression and promotes cell proliferation. |
| Molecular mechanism: |
ceRNA mechanism: HBV-upregulated hsa_circ_0001098 sponges miR-2110 to modulate IGF2BP1 expression. |
| Biological pathway or process: |
proliferation (promotes); ceRNA regulation (promotes) |
| Detected method: |
Q
S
|
| Validation methods: |
RT-qPCR; RNA-seq; Clinical Sample Validation; RIP (RNA Immunoprecipitation); Luciferase Reporter Assay; Transfection; Colony Formation Assay; Western Blot; Bioinformatics Analysis |
| Clinical significance: |
Potential therapeutic target for HBV-induced HCC. |
| Description: |
hsa_circ_0001098 is up-regulated in HBV-positive HepAD38 cells and HBV-related HCC tissues. It promotes HCC cell proliferation and progression through a ceRNA mechanism in which hsa_circ_0001098 sponges miR-2110 to increase IGF2BP1 expression. |
| Confidence score: |
0.7165 |